Skip to content

Innoviva, Inc. INVA Accrued interest

Accrued interest at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$2.19M
Royalty Pharma logo
Royalty PharmaRPRX
$25.3M+31.6%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$26.04M

Other financials

Income statement

See full
Revenue$98.0M+10.6%
Gross profit$75.8M+3.4%
Operating income$38.2M-7.9%
Net income$186.6M+501%
EPS (diluted)$2.22+400%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total debt$269.4M-40.3%
Total equity$1.3B
Total assets$1.8B+46.4%

Cash flow

See full
Operating cash flow$35.3M-27.4%
CapEx$492.0K
Free cash flow$34.8M-28.4%

Valuation

See full
Market cap$1.74B+51.8%
Enterprise value$1.41B+9.7%
P/E3.5×
P/S4.2×+1.0×

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestPayableCurrent.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s accrued interest.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s accrued interest?
Innoviva, Inc. (INVA) reported accrued interest of $231K in Q1 2026.
How has Innoviva, Inc.'s accrued interest changed year-over-year?
Innoviva, Inc.'s accrued interest decreased by 72.3% year-over-year, from $833K to $231K.
What is the long-term trend for Innoviva, Inc.'s accrued interest?
Over 5 years (2020 to 2025), Innoviva, Inc.'s accrued interest has grown at a -17.2% compound annual growth rate (CAGR), from $4.15M to $1.62M.
What does accrued interest mean?
Interest expense accrued but not yet paid on outstanding debt obligations, based on contractual interest rates and time elapsed.